Press Releases April 24, 2026 06:30 AM

BOSS Zhipin's Ongoing Share Repurchases Cross the RMB1 Billion Mark in 2026

KANZHUN LIMITED exceeds RMB1 billion in share repurchases in 2026, reinforcing shareholder value commitment.

By Derek Hwang BZ
BOSS Zhipin's Ongoing Share Repurchases Cross the RMB1 Billion Mark in 2026
BZ

KANZHUN LIMITED, trading as BOSS Zhipin, continues its aggressive share repurchase program in 2026, crossing RMB1 billion invested in buybacks year-to-date. Recent purchases included 597,224 shares using RMB27.3 million, demonstrating strong commitment to enhancing shareholder value.

Key Points

  • KANZHUN LIMITED has repurchased over RMB1 billion worth of shares so far in 2026.
  • On April 23, the company used RMB27.3 million to buy back 597,224 ordinary shares.
  • The ongoing share repurchase program signals confidence in the company’s future and benefits shareholders by potentially boosting stock value.

BEIJING, April 24, 2026 (GLOBE NEWSWIRE) -- KANZHUN LIMITED (“BOSS Zhipin” or the “Company”) (Nasdaq: BZ; HK: 2076) today announced the continued execution of its share repurchase program, utilizing over RMB27.3 million to repurchase 597,224 ordinary shares on April 23. With this latest repurchase, the Company has deployed over RMB1 billion toward share repurchases year-to-date in 2026. This effort underscores the Company's ongoing commitment to delivering value to shareholders.


Risks

  • Future share repurchase activity depends on the company's financial health and market conditions, which may vary.
  • Large allocation of capital to buybacks could limit funds available for growth initiatives or investments.
  • Market volatility or downturns could negatively affect repurchase efficacy or shareholder returns.

More from Press Releases

Fiverr Announces First Quarter 2026 Results Apr 29, 2026 Nayax to Report 2026 Q1 Earnings on May 12, 2026 Apr 28, 2026 Xunlei Filed Its Annual Report on Form 20-F for Fiscal Year 2025 Apr 28, 2026 Mesoblast Achieves Patient Recruitment Target in Pivotal Phase 3 Trial for Chronic Low Back Pain Apr 28, 2026 Syntec Optics (Nasdaq: OPTX) Announces Pricing of $20 Million Underwritten Public Offering of Common Stock Apr 28, 2026